GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Copyright © 2025 MarketWatch, Inc. All rights reserved.
J''K Assembly Approves Rs 9,953 Crore for Key Departments The Jammu and Kashmir Assembly has passed grants totaling over Rs 9,953 crore for seven key departments, including agriculture and ...
Pre-Market: 4:30:57 a.m. EDT Loading Chart for GSK ...
3 Year 86.59% 86.61% 35.40% 37.37% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback